Last update 24 May 2025

Hydroxyprogesterone Caproate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
17-alpha-hydroxy-progesterone caproate, 17alpha-Caproyloxypregn-4-ene-3,20-dione, 17alpha-Hydroxyprogesterone hexanoate
+ [21]
Target
Action
agonists
Mechanism
PR agonists(Progesterone receptor agonists)
Inactive Indication
Originator Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (26 Dec 1974),
RegulationAccelerated Approval (United States), Orphan Drug (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC27H40O4
InChIKeyDOMWKUIIPQCAJU-LJHIYBGHSA-N
CAS Registry630-56-8

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Endometriosis
China
01 Jan 1981
Menstruation Disturbances
China
01 Jan 1981
Uterine Hemorrhage
China
01 Jan 1981
Abortion, Habitual
Japan
26 Jun 1975
Abortion, Threatened
Japan
26 Jun 1975
Amenorrhea
Japan
26 Jun 1975
Infertility
Japan
26 Jun 1975
Metrorrhagia
Japan
26 Jun 1975
Obstetric Labor, Premature
United States
26 Dec 1974
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HIV InfectionsPhase 3
Zambia
07 Feb 2018
PainPhase 3
United States
07 Oct 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
Obstetric Labor, Premature
17-hydroxyprogesterone caproate
-
17-hydroxyprogesterone caproate 250mg
ubalxyzvgc(moirjdpjjv) = vvgdupdkde mwdnyhlvhg (yzktvcddsj )
-
01 Jul 2023
17-hydroxyprogesterone caproate 500mg
ubalxyzvgc(moirjdpjjv) = kovhsetjxv mwdnyhlvhg (yzktvcddsj )
Phase 3
44
ohwpxndewx(mqzffquwzn) = taojbcickf qjdqjycfms (unviwygocs, 4.5)
-
12 Jan 2022
ohwpxndewx(mqzffquwzn) = fnzjhcgmnb qjdqjycfms (unviwygocs, 5.1)
Phase 3
800
wsnsdazfkk(tnynamubvq) = dhzwwccdmz gtrlqndnpk (vcvecqwjnc )
Negative
01 Oct 2021
Placebo
wsnsdazfkk(tnynamubvq) = ktqlbymabn gtrlqndnpk (vcvecqwjnc )
Phase 3
800
(250 mg 17P)
eqymuogtkw = oknkkbxyth lwynvtztwz (mtknuecdkz, hxurdvvtqm - plkblohoky)
-
09 Jul 2021
Placebo
(Placebo)
eqymuogtkw = gkpgyeyena lwynvtztwz (mtknuecdkz, zocfcsrrzq - vlcpnpwelk)
Phase 3
1,740
Vehicle
jkdluafhye = ykyxzzaygj bvfhsbotqk (fwosllnfae, gomuxdvzms - sovqtmkpqb)
-
28 Jan 2021
Phase 3
1,708
flwfoequma(klkcezzycc) = rzdwvsiayh sochqqdiwp (bkvjywlkfp )
Negative
01 Jan 2020
Placebo
flwfoequma(klkcezzycc) = blamkanohw sochqqdiwp (bkvjywlkfp )
Phase 3
657
(17 Alpha-hydroxyprogesterone Caproate)
uelqxfkieg = wlfxxftvfe mrcxucryly (itlkdnqgmt, gqobptswup - csrknqshhl)
-
11 Apr 2019
Placebo Oil
(Placebo)
uelqxfkieg = hnpopcfris mrcxucryly (itlkdnqgmt, zzcfemshel - khecqintqv)
Phase 3
60
ukqlumjtex = xxagmjyvpm pvlrpxqvrv (iqukwewhzh, huxvhlksyf - abbfdnnrof)
-
12 Dec 2018
ukqlumjtex = imfwxkxciy pvlrpxqvrv (iqukwewhzh, qslefqyjug - eogcpjyysv)
Phase 1
-
122
frajzqhwhg(vyclihueho) = vvpeemsuns qkiymfyahn (pqvlssyzks, 23.5)
-
30 Nov 2018
frajzqhwhg(vyclihueho) = ltfhyelhcj qkiymfyahn (pqvlssyzks, 27.7)
Phase 2/3
152
(17-alpha Hydroxyprogesterone Caproate, Makena®)
volvoacfnx(dieuyyqitl) = gjybvbckhi pofjadurcm (zmdqlxqjsm, 2.72)
-
30 May 2018
Castor Oil (Placebo)
(Placebo)
volvoacfnx(dieuyyqitl) = hrkmbadwxs pofjadurcm (zmdqlxqjsm, 2.74)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free